NEOCUTIS

NEOCUTIS uses anti-aging peptides to boost collagen and elastin for firmer, resilient-looking skin.

Experience visible results in 6 days with BIO SERUM FIRM. This anti-aging serum features human growth factors and proprietary peptides to diminish the appearance of fine lines and improve firmness.

Human growth factors in skincare support collagen production to reduce signs of aging.

NEOCUTIS Enhancers provide targeted solutions for specific skin concerns.

The page explains how collagen, elastin, and hyaluronic acid breakdown contributes to aging skin, including fine lines, wrinkles, and sagging.

NEOCUTIS develops skincare using medical-grade formulations backed by research.

NEOCUTIS offers customer service for product questions, support, and skincare advice.

The page lists authorized NEOCUTIS physicians and skincare professionals for expert guidance.

NEOCUTIS sells medical-grade skincare products with growth factors and peptides for anti-aging.

Merz Aesthetics reintroduces the Neocutis Journée Revitalizing Day Cream SPF 30, a skincare product designed for daily use with sun protection. The cream combines hydration and broad-spectrum UV defense for skin revitalization. This marks the product’s return after a period of discontinuity.

Jul 2026The Dermatology DigestNews article

Merz Aesthetics reintroduces the Neocutis Journée Revitalizing Day Cream SPF 30, a dermatologist-tested day cream featuring its original formula. The product combines skin revitalization, antioxidant protection, and broad-spectrum sun defense in a single multi-benefit cream, leveraging the brand’s growth factor technology. Neocutis relaunches the offering by popular demand, targeting consumers seeking simplified yet effective daily skincare solutions.

Jul 2026American Med Spa AssociationNews article

Merz Pharma Group acquires Neocutis’ cosmetics, over-the-counter, and prescription skin care businesses. The Swiss dermatology company’s portfolio includes branded skin care products targeting dermatological concerns. The deal expands Merz’s presence in the global skin care market beyond pharmaceuticals.

Aug 2013PracticalDermatologyNews article

Merz Pharma Group acquires Neocutis S.A., expanding its portfolio in aesthetic injectables. The move strengthens Merz’s position in dermatological treatments and regenerative medicine. Neocutis specializes in bioengineered skin substitutes for wound care and aesthetic applications.

Jul 2013Plastic Surgery PracticeNews article